The safety and efficacy of Adalat retard in children below 18 years of age has not been established. From the clinical evidence available a specific prenatal risk has not been identified, although an increase in perinatal asphyxia, caesarean delivery, as well as prematurity and intrauterine growth retardation have been reported.
No accumulation of the substance after the usual dose was reported during long-term treatment. Disturbances of consciousness to the point of coma, a drop in blood pressure, tachycardia, bradycardia, hyperglycaemia, metabolic acidosis, hypoxia, cardiogenic shock with pulmonary oedema.
Fertility In single cases of in vitro fertilisation calcium antagonists like nifedipine have been associated with reversible biochemical changes in the spermatozoa's head section that may result in impaired sperm function. If you have chest pains after taking your first dose of Adalat retard. Adalat Retard Tablets come in blister packs of 60 tablets.
The direct maternal adverse effects are related to the vasodilation caused by nifedipine and are primarily headache and facial flushes. Verhaert and van Acker You may be able to use Adalat retard but only after special consideration and agreement by your doctor. Toxic Epidermal Necrolysis Photosensitivity allergic reaction Palpable purpura.
It may also lead to an increase in your blood sugar level or an increase in the acidity of your blood, swelling in the lungs, low blood oxygen levels and disturbances in consciousness, possibly leading to unconsciousness.
Do not use after the expiry date which is marked on both the outer carton and on each blister strip of tablets. You may be advised not to take Adalat retard. Before you contact this company: Adalat retard may interfere with the results of certain urine tests.
Abstract Nifedipine Adalat is marketed as an anti-hypertensive agent. The next steps forward in reducing the impact of preterm birth. Adalat retard must not be administered to patients with known hypersensitivity to the active substance, or to other dihydropyridines because of the theoretical risk of cross-reactivity, or to any of the excipients listed in section 4.
Things you must not do Do not give this medicine to anyone else, even if their symptoms seem similar to yours. Drugs that are known inhibitors of the cytochrome P 3A4 system, and which may therefore lead to increased plasma concentrations of nifedipine include, for example: